CAMPENNI', Alfredo
 Distribuzione geografica
Continente #
EU - Europa 18.786
NA - Nord America 11.664
AS - Asia 6.996
SA - Sud America 2.349
AF - Africa 221
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 14
Totale 40.049
Nazione #
US - Stati Uniti d'America 11.414
RU - Federazione Russa 7.509
IT - Italia 5.120
SG - Singapore 2.833
BR - Brasile 2.037
CN - Cina 1.951
IE - Irlanda 1.650
SE - Svezia 1.588
HK - Hong Kong 802
DE - Germania 650
FR - Francia 492
VN - Vietnam 406
FI - Finlandia 354
NL - Olanda 343
GB - Regno Unito 328
UA - Ucraina 303
IN - India 294
BD - Bangladesh 126
CA - Canada 120
PL - Polonia 120
AR - Argentina 102
TR - Turchia 85
IQ - Iraq 78
ZA - Sudafrica 76
MX - Messico 73
CZ - Repubblica Ceca 59
PK - Pakistan 53
BE - Belgio 50
JP - Giappone 50
AT - Austria 47
EC - Ecuador 45
CO - Colombia 38
UZ - Uzbekistan 37
ES - Italia 36
ID - Indonesia 35
MA - Marocco 33
CL - Cile 32
CI - Costa d'Avorio 31
VE - Venezuela 29
SA - Arabia Saudita 27
AE - Emirati Arabi Uniti 23
IR - Iran 23
LT - Lituania 22
AZ - Azerbaigian 21
PY - Paraguay 20
UY - Uruguay 19
CH - Svizzera 18
KE - Kenya 18
TN - Tunisia 18
PE - Perù 16
AU - Australia 15
DZ - Algeria 14
KZ - Kazakistan 14
EG - Egitto 13
PH - Filippine 13
NP - Nepal 12
IL - Israele 11
PS - Palestinian Territory 11
DO - Repubblica Dominicana 10
JO - Giordania 10
KG - Kirghizistan 10
OM - Oman 10
PA - Panama 10
AL - Albania 9
BO - Bolivia 9
MY - Malesia 9
RO - Romania 9
BG - Bulgaria 8
JM - Giamaica 8
LB - Libano 8
NO - Norvegia 8
BY - Bielorussia 7
CR - Costa Rica 7
HU - Ungheria 7
PT - Portogallo 7
EU - Europa 6
GE - Georgia 6
LV - Lettonia 6
RS - Serbia 6
XK - ???statistics.table.value.countryCode.XK??? 6
DK - Danimarca 5
GR - Grecia 5
GT - Guatemala 5
HN - Honduras 5
NI - Nicaragua 5
TH - Thailandia 5
EE - Estonia 4
HR - Croazia 4
QA - Qatar 4
AM - Armenia 3
BH - Bahrain 3
BN - Brunei Darussalam 3
KR - Corea 3
LK - Sri Lanka 3
MD - Moldavia 3
MU - Mauritius 3
NG - Nigeria 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
AO - Angola 2
Totale 40.007
Città #
Moscow 2.161
Ashburn 1.679
Dublin 1.646
Singapore 1.543
Dallas 1.396
Chandler 1.381
Nyköping 862
Hong Kong 797
Beijing 721
Jacksonville 664
San Jose 626
Milan 452
Rome 394
The Dalles 391
Messina 308
Princeton 275
Los Angeles 261
Lauterbourg 253
Dearborn 246
Medford 240
Munich 239
New York 222
Cambridge 204
Des Moines 200
Ann Arbor 186
Naples 178
São Paulo 162
Boardman 129
Buffalo 126
Ho Chi Minh City 108
Hyderabad 97
Warsaw 96
Council Bluffs 95
Turku 94
Turin 93
Bremen 91
Jinan 91
Bari 85
Lancaster 85
Pune 84
Catania 83
Bologna 82
Redondo Beach 82
Palermo 81
Tianjin 80
Hanoi 76
Wilmington 75
Guangzhou 67
Florence 64
Dong Ket 61
Woodbridge 61
Santa Clara 57
Belo Horizonte 56
Rio de Janeiro 55
San Mateo 55
Frankfurt am Main 54
Nanjing 53
Shenyang 53
Helsinki 51
Brussels 50
Genoa 50
Orem 50
Brooklyn 44
Johannesburg 44
Brasília 43
Denver 43
Montreal 42
London 40
Houston 39
Tokyo 36
Zhengzhou 35
Ningbo 34
Chennai 33
Chicago 32
Porto Alegre 32
Seattle 32
Stockholm 32
Tashkent 31
Abidjan 30
Brno 30
Atlanta 29
Vienna 29
Shenzhen 28
Brescia 27
Hebei 27
Trieste 27
Changsha 26
Nanchang 26
Baghdad 25
Cagliari 25
Curitiba 25
Hangzhou 25
Modena 25
Toronto 25
Guarulhos 24
Haikou 24
Salvador 24
Falls Church 23
Nuremberg 23
Parma 23
Totale 21.519
Nome #
LA LOCALIZZAZIONE ISTMICA DEL NODULO TIROIDEO MALIGNO RAPPRESENTA UN FATTORE ADDIZIONALE DI RISCHIO PER METASTASI IN PAZIENTI AFFETTI DA CARCINOMA DIFFERENZIATO DELLA TIROIDE (CDT) A BASSO RISCHIO 4.649
EMIAGENESIA TIROIDEA, MORBO DI BASEDOW-GRAVES E CARCINOMA DIFFERENZIATO DELLA TIROIDE: UN’ASSOCIAZIONE MOLTO RARA. 326
99mTc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology 275
131I RADIOIODINE THERAPY (RIT) OF HYPERTYROIDISM DUE TO GRAVES’ DISEASE (GD) OR UNI-MULTINODULAR TOXIC GOITER (NTG): OUR EXPERIENCE 257
131I Radioiodine therapy (RIT) of hyperthyroidism due to Graves' disease (GD) or uni-multinodular toxic goiter (NTG): our experience 247
Acute liver damage following intravenous glucocorticoid treatment for Graves’ ophthalmopathy 239
Abscesualized gliomas:predictive value of 99Tc-Leukoscan 233
HYPERPARATHYROIDISM FROM MEDIASTINAL PARATIROID ADENOMA. CASE REPORT. 210
ACCIDENTAL DISCOVERY OF LUNG METATSTASES FROM DIFFERENTIATED THYROID CANCER BY TC-99M PERTECHNETATE SCAN IN A PATIENT WITH SECONDARY HYPERPARATHYROIDISM 208
A didactic experiment showing the Compton scattering by means of a clinical gamma camera 205
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 201
99mTc-HM-PAO SPECT evaluation of regional cerebral blood flow modifications after paediatric hydrocephalus shunting 200
99mTc-MIBI SPECT in the differential diagnosis of brain metastases 200
2 years-survival analysis of patients with non-small cell lung cancer by means of 2deoxy-2-[18F]fluoro-D-glucose positron emission tomography: implications of maximum standardized uptake value (SUVmax) 200
Abnormal 99mTc-MIBI Uptakein left lung mimicking a neoplastic lesion in a young woman with nodular goiter. A rare pitfall of 99mTc-MIBI 200
An analytical model for improving absorbed dose calculation accuracy in non spherical autonomous functioning thyroid nodule 196
Abnormal radioiodine uptake on post-therapy whole body scan and sodium/iodine symporter expression in a dermoid cyst of the ovary: report of a case and review of the literature 195
Cell proliferation parameters and apoptosis indices in pituitary macroadenomas 194
AN UNUSUAL CASE OF MARINE-LENHART SYNDROME. 193
99mTc-Methoxy-Isobutil-Isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 191
Association of parathyroid carcinoma and thyroid disorders: A clinical review 191
Association of autonously functioning ("hot") thyroid nodules with Hashimotos' thyroiditis (HT). 190
99mTc-methoxy-isobutyl-isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 188
ABLAZIONE RADIOMETABOLICA DEL RESIDUO TIROIDEO POST-CHIRURGICO DOPO STIMOLO CON TSH UMANO RICOMBINANTE (rhTSH) IN PAZIENTI CON OFTALMOPATIA DI GRAVES (OG) DI GRADO MODERATAMENTE SEVERO E SEVERO: STUDIO PROSPETTICO RANDOMIZZATO IN SINGOLO CIECO 187
Accidental discovery of lung metastases from differentiated thyroid cancer by 99mTc sodium pertechnetate scan in a patient with secondary hyperparathyroidism 183
Abnormal radioiodine uptake in an abdominal dermoid cyst in a patient affected by differentiated thyroid cancer 183
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients 183
BRAFV600Emutation is associated with increased prevalence of contralateral lymph-node metastases in low and low-to-intermediate risk papillary thyroid cancer 183
Hyperthyroidism treatment with calculated activity of 131-Radioiodine: our experience 181
ACCUMULO DI TECNEZIO IN METASTASI POLMONARI DA CARCINOMA DIFFERENZIATO TIROIDEO (CDT): UNA RARA EVENIENZA 181
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 181
ANALYSIS OF THE FACTORS CONDITIONING THE CLINICAL COURSE OF DIFFERENTIATED THYROID CARCINOMA IN CHILDREN AND YOUNG ADULTS 179
Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? 178
HER2 analysis in sporadic thyroid cancer of follicular cell origin 177
Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients 175
A simplified method for kidney dosimetry in Lu-177 therapies based on single SPECT-CT and multiple external probe measurements 174
Radiometabolic therapy with 131I for the ablation of the thyroid remnant in patients affected by differentiated thyroid cancer: comparison between four different activities 173
GASTROINTESTINAL SEQUELAE IN SURVIVORS OF CONGENITAL DIAPHRAGMATIC HERNIA 172
Braf V600E and 99m-TC MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy. 172
Association of primary hyperparathyoidism (p-hyperPTH) with nodular toxic goiter (NTG): a prospective study at an outpatient osteoporosis service. 171
ACCUMULO DI RADIOIODIO IN MIELOMENINGOCELE SECONDARIO A SPINA BIFIDA OCCULTA: PRIMA EVIDENZA DI CONDIZIONE SIMULANTE UNA METASTASI VERTEBRALE DI CARCINOMA DIFFERENZIATO DELLA TIROIDE 171
A model to evaluate S values for beta-gamma emitting radionuclides in cubic voxels 171
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low risk differentiated thyroid cancer? 171
Combined BRAFV600Eanalysis and99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation 171
Parathyroid carcinoma presenting as normocalcemic hyperparathyroidism 170
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy ina real life scenario 169
Oxidative stress as a key feature of autoimmune thyroiditis: an update 169
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG) 168
Aplotipi del microsatellite D7S6440, localizzato nell'introne 9 del gene HIPK2, come marcatori molecolari della tiroidite di Hashimoto 168
Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: A new quantitative method for improving diagnostic accuracy 166
Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis 166
Oxidative Stress and Advanced Glycation End Products in Hashimoto's Thyroiditis 165
Association of autonomously functioning thyroid nodules (AFTNs) with Hashimoto's thyroiditis (HT) 164
Clinical usefulness of 99mTc-MIBI scintigraphy in the postsurgical evaluation of patients with differentiated thyroid cancer 164
Abla zione radiometabolica dopo rhTSH del residuo tiroideo post -chirurgico in pazienti con orbitopatia di Graves moderatamente severa e severa 163
Association between primary hyperprathyroidism (p-hyperPTH) and nodular toxic goiter (NTG): a prospective study at an outpatient service for osteoporosis 162
Coexistence of diffuse large B-cell lymphoma and papillary thyroid carcinoma in a patient affected by hashimoto's thyroiditis 162
ATYPICAL PRESENTATION OF PARATHYROID CARCINOMA (PC): REPORT OF TWO CASES 160
Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: coexistent polymorphism of the TSHR and Gsα genes 159
Autoimmune comorbidities in Hashimoto's thyroiditis: different patterns of association in adulthood and childhood/adolescence 159
Internal Dosimetry of Ellipsoidal Targets: models and applications 158
FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA PRESENTING AS A TOXIC NODULE IN AN ADOLESCENT GIRL 158
Hyperthyroidism treatment with calculated activity of 131–radioiodine 158
ASSOCIATION OF PRIMARY HYPERPARATHYROIDISM (P-HYPERPTH) WITH NODULAR TOXIC GOITER (NTG): A PROSPECTIVE STUDY AT AN OUTPATIENT OSTEOPOROSIS SERVICE 157
An uncommon case of Marine-Lenhart syndrome 157
Evaluation Of Absorbed Doses To Autonomous Thyroid Nodules During 131I Treatment Of Hyperthyroidism: Traditional Approach Versus Monte Carlo Calculation 156
Iodine-131 treatment of hyperthyroidism: our experience 155
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low-risk differentiated thyroid cancer? 155
A model for computing absorbed fractions for alpha particles in ellipsoidal volumes 154
Associazione tra noduli tiroidei iperfunzionanti (noduli "caldi") e tiroidite di Hashimoto 153
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG): a prospective study at an outpatient osteoporosis service 153
Association of autonomously functioning thyroid nodules with Hashimoto’s thyroiditis: study on a large series of patients 153
I livelli sierici del recettore solubile per i prodotti avanzati di glicazione sono ridotti in pazienti pediatrici con tiroidite di Hashimoto 153
Isthmus topography is a risk factor for persistent disease in patients with differentiated thyroid cancer 153
Differentiated thyroid carcinoma in lingual thyroid 152
BRAFV600E and 99mTc-MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy 151
Supra-Acetabular Brown Tumor due to Primary Hyperparathyroidism Associated with Chronic Renal Failure 150
BRAF and RAS mutations in differentiated thyroid cancer of patients with low-risk to intermediate-risk treated with radioiodine therapy 150
Hashimoto's thyroiditis is a frequent association of primary hyperparathyroidism, of which it modifies biochemical and bone density indices 149
La paratiroidectomia radioguidata 149
Comparing radioiodine abdominal absorbed dose in differentiated thyroid cancer patients undergone thyroid remnant ablation in either levo-thyroxine withdrawal or after rhtsh stimulation 149
PRRT retreatments: renal function evaluation 149
Scintigraphic evaluation of colonic motility in patients with anorectal malformations and constipation 148
Meningocele due to closed spina bifida mimicking a metastasis of papillary thyroid carcinoma on whole body radioactive iodine scan 148
I carcinomi tiroidei differenziati. 147
IODINE-131 TREATMENT OF HYPERTHYROIDISM:OUR EXPERIENCE. 147
ATYPICAL PRESENTATION OF PARATHYROID CARCINOMA (PC): REPORT OF TWO CASES 147
Effetto proinfiammatorio degli oligosaccaridi dell'acido ialuronico in tireociti e fibroblasti umani: ruolo dei recettori tool-like di tipo 2(TLR-2) e 4(TLR-4) 147
Advances in Monte Carlo patient-specific internal dosimetry for 90 Y-TARE treatments. 146
Association of autonomously functioning ("hot") thyroid nodules with Hashimoto's thyroiditis 146
Is %ΔSUVmax a Useful Indicator of Survival in Patients with Advanced Nonsmall-Cell Lung Cancer? 146
An User-Friendly Approach to the Evaluation of Skin and Eye Lens Doses to the Operators in Nuclear Medicine through Dedicated Monte Carlo Simulations in GAMOS 146
Meningocele mimicking a metastasis of papillary thyroid carcinoma 145
Geriatric primary hyper-parathyrodism 145
Hashimoto's thyroiditis (HT) is a frequent association of primary hyperparathyroidism (p-hyperPTH), of which it modifies biochemical and bone density indices 144
Importanza del campionamento precoce del TSH, basale e stimolato dal TRH, nell'ipotiroidismo subclinico 144
High-grade gliomas associated with abscess: description of two rare cases and role of 99mTc-Leukoscan 143
Hepatocyte growth factor/C-met axis in thyroid cancer: From diagnostic biomarker to therapeutic target 143
Cystic Fibrosis as a Cause of Malabsorption and Increased Requirement of Levothyroxine 143
un caso di carcinoma delle paratiroidi associato ad adenoma autonomo omolaterale della tiroide 142
Totale 21.728
Categoria #
all - tutte 124.356
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.356


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021132 0 0 0 0 0 0 0 0 0 0 0 132
2021/20221.921 22 247 27 74 62 23 103 100 32 318 283 630
2022/20235.160 395 526 245 381 402 575 78 303 2.006 40 150 59
2023/20242.469 116 181 145 202 162 425 123 150 99 295 192 379
2024/20258.397 312 217 314 595 497 372 387 1.565 1.634 559 741 1.204
2025/202618.290 1.008 1.202 1.418 1.173 1.461 3.739 2.149 2.244 2.312 906 362 316
Totale 40.585